https://www.selleckchem.com/pr....oducts/pqr309-bimira
032). No significant increase in the impact of pain on instrumental or elementary activities was observed over time. The frequency of arthralgia significantly increased at 3months in patients with ovarian cancer versus those with colorectal cancer (odds ratio 19.50; 95% confidence interval 4.53-83.98; P 0.001). Bev‑including regimens tend to be associated with a significant increase in the frequency of arthralgia in women treated for ovarian cancer. Physicians should be aware of this side effect. NCT03455907, date of reg
Like
Comment
Share
